At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03347 TIGERMED
Not Yet Opened 01-20 16:08:04
52.400
+0.550
+1.06%
High52.800
Low51.450
Vol1.26M
Open51.550
D1 Closing51.850
Amplitude2.60%
Mkt Cap45.12B
Tradable Cap6.45B
Total Shares861.00M
T/O65.59M
T/O Rate1.02%
Tradable Shares123.12M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Shanghai Zhejiang Chamber of Commerce Rotating Presidency Transferred to Tigermed Chairman Ye Xiaoping
Hong Kong Stocks Movement | CRO Concept Stocks Lead Gains with WUXI APPTEC (02359) Forecasting Doubled Net Profit; Sector Poised for "Davis Double Play"
Hong Kong Stocks Movement | CRO Concept Stocks Show Strong Performance, External Demand Recovery Clearly Reflected in Earnings, Domestic Demand Recovery Extends from Front-end to Back-end
Hong Kong Stocks Surge: CRO Concept Stocks Rally in Afternoon Session with WUXI BIO (02269) Up Over 7%; Analysts Highlight Industry Consolidation Trend
Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The Company operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The Company conducts its businesses in the domestic and overseas markets.